29.4 - Patients with advanced cirrhosis should receive blood products to correct coagulation abnormalities before invasive procedures

Description

Presentation Style: Debate

Learning Objectives:

• Understand the balance between pro-hemorrhagic and pro-thrombotic tendencies in patients with cirrhosis at different stages
• Understand the limitations of standard coagulation tests (INR, platelet count, fibrinogen) in predicting risk of post-procedural bleeding in patients with cirrhosis
• Gain knowledge on the risk and potential benefits of blood product transfusion prior to invasive procedures in patients with cirrhosis

Debater(s):

• Dr. Andres Cardenas, MD, MMSC, PHD, AGAF, FAASLD, Assosciate Professor of Medicine, University of Barcelona
• Dr. Guadalupe Garcia-Tsao, MD, Professor of Medicine, Yale University School of Medicine